%20PHARMA%20PRIVATE%20LIMITED%20-%20285543%2012-Sep-2014_files/image002.jpg){kind=small}
MIRA
INFORM REPORT
|
Report Date : |
12.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
ACEBRIGHT (INDIA) PHARMA PRIVATE LIMITED (w.e.f. 24.04.2012) |
|
|
|
|
Formerly Known
As : |
CDYMAX (INDIA) PHARMA PRIVATE LIMITED (w.e.f. 06.08.2009) INTERMED LABS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
116/117 Kiadb Industrial Area, Jigani, 2nd Phase, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
27.10.1994 |
|
|
|
|
Com. Reg. No.: |
08 - 016472 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 33.400 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U85110KA1994PTC016472 |
|
|
|
|
TAN No. : |
BLRI00919C |
|
|
|
|
PAN No.: |
AAACI8027N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Exporter of active pharmaceutical ingredient (API) |
|
|
|
|
No. of Employees
: |
150 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 590000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow But Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track record. Rating reflects moderate financial risk profile due to loss incurred
by company in the year 2012 – 13. However, trade relation are fair. Business is active. Payment terms
are slow but correct. The company can be considered for business dealing with some caution. |
NOTES:
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
As per the latest IMF study, the total weigh of emerging markets in the
GDP of the world on a purchasing power parity basis has seen a sizeable shift.
It highlights how as against 51 % in 2005, the emerging economies now account
for close to 56 % of the global purchasing power GDP as per the latest survey.
And with the emerging economies growing at a faster rate than their developed
counterparts, there are every possibility that the their share goes up further
in the coming years. China may surpass the US over the next few years.
Politics and economics are very intricately connected. They tend to
influence each other in ways that could be very complex and far-reaching. The
prospects of the India’s economy have been seriously compromised due to
political corruption. High inflation, poor standard of living are to a great
extent a result of rampant corruption in the country. China on the other hand,
seems to be facing diametrically opposite challenge. American hedge fund
manager Jim Chanos has been keenly following the political and economic
development in the dragon economy and has figured out something that is quite
worrying. He is of the view that the Chinese economy could be heading toward
trouble on account of new Chinese President Xi Jingping’s very aggressive
anti-corruption drive. Chanos believes tat many things such as apartment sales,
luxury products, etc. were largely bought with dirty money. And it is now
beginning to impact consumption. This may indeed be bad news for an economy
that is struggling to transition from an investment-driven export-oriented
economy to a domestic consumption-driven economy.
A study published by Firstpost has revealed that asset classes like real
estate and equities were the biggest beneficiaries of the liberalization policies.
A firm called Ciane Analytics studied returns from assets including
equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate
outperformed every other asset classes during the 23-year period with an
annualized return of 20 % ! Equities came in second with annualized return of
15.5 % ! However, while these returns may seem mouthwatering, the fact is that
the return from equities adjusted for inflation came down to just 7.1 %.
Some brief news are as under
. R-Power to buy Jaypee’s hydro assets
. Investors await justice in NSEL case
. India seeks MFN status from Pakistan ahead of meeting
. Ukrain’s clashes with rebels hinder MH17 crash investigation
. India exploring merger of state-owned hydro PSUs
..Higher costs weigh down profit growth to slowest in 9 quarters
..Wal-Mart to expand wholesale business in India
. GMR group moves to strengthen balance sheet
. Central Bank to sell 4 % stake to Life Insurance Corporation
. Tata Chemicals plans to raise up to Rs 10000 mn.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE |
|
Rating |
Long term bank facilities: BB – (Suspended) |
|
Rating Explanation |
Inadequate credit quality and high credit risk. |
|
Date |
13.02.2014 |
|
Rating Agency Name |
CARE |
|
Rating |
Short term bank facilities: A4 (Suspended) |
|
Rating Explanation |
Minimal degree of safety and very high credit risk. |
|
Date |
13.02.2014 |
Reason for suspension: company has not furnished information required.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY
|
Name : |
Mr. Ganesh |
|
Designation : |
Accounts Executive |
|
Contact No.: |
91- 8110-415520 |
|
Date : |
10.09.2014 |
LOCATIONS
|
Registered Office/ Factory : |
116/117, KIADB Industrial Area, Jigani 2nd Phase, Bangalore –
560105, Karnataka, India |
|
Tel. No.: |
91-8110-415545 |
|
Fax No.: |
91-8110-415540 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Sales/ Marketing/ Branch Office : |
B-Wing, 206/207, Classique
Centre, Mahal Industrial Estate, Off Mahakali Caves Road, Andheri (East),
Mumbai – 400093, Maharashtra, India |
|
Tel. No.: |
91-22-26879344 |
DIRECTORS
As on: 30.09.2013
|
Name : |
Mr. Manorama Avinash |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
24, Srija, 9th Cross, 5th Main, 1st
Stage, RK Layout, Padmanabhaanaagr, Bangalore – 560070, Karnataka, India |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
23.04.1972 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
07.05.2011 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
03457332 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Ying Kan |
|||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
|||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Rm. 1302, No. 8, Lane 1089, Dingxiang Road, Shanghai - 200135 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
04.03.1973 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
07.05.2011 |
|||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
03479630 |
|||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
||||||||||||||||||||||||||||||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Ganesh |
|
Designation : |
Accounts Executive |
|
|
|
|
Name : |
Shashidhara G. S. and Company |
|
Designation : |
Company secretaries |
|
Address : |
No. 993A, ‘SECRETARIAT’, 37th Cross, 22nd Main,
4th T Block, Jayanagar, Bangalore – 560041, Karnataka, India |
|
Tel No.: |
91-40-22455141 / 26534024 |
|
Mobile No.: |
91-9880461710 / 9844061710 |
|
Email : |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on: 30.09.2013
|
Names of Shareholders |
|
No. of Shares |
|
Medsyn Laboratories Private Limited, India |
|
8775 |
|
Couplet Limited, British Virginia Islands |
|
325225 |
|
Manorama Avinash |
|
1 |
|
|
|
|
|
Total |
|
334001 |
Equity Share Break up (Percentage of Total Equity)
As on: 30.09.2013
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional investor(s),
Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s)
or Overseas Corporate bodies or Others |
97.37 |
|
Bodies corporate |
2.63 |
|
Total |
100.00 |
%20PHARMA%20PRIVATE%20LIMITED%20-%20285543%2012-Sep-2014_files/image010.gif)
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of active pharmaceutical ingredient (API) |
|
|
|
|
Products : |
Bulk Drugs |
|
|
|
|
Exports : |
|
|
Products : |
Finished Goods |
|
Countries : |
·
South Africa ·
Europe |
|
|
|
|
Imports : |
|
|
Products : |
Raw Material |
|
Countries : |
China |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, Advance Payment and LC |
|
|
|
|
Purchasing : |
Cash, Advance Payment and LC |
PRODUCTION STATUS AS ON 31.03.2013
|
Particulars |
Unit |
Licensed
Capacity |
Installed
Capacity |
Actual
Production |
|
|
|
|
|
|
|
Bulk Drugs |
M.T. Per Annum |
NA |
200 |
14.25 |
|
|
|
|
|
|
NOTES:
The installed capacity is as certified by
management and verified by Auditors since this is a Technical matter.
GENERAL INFORMATION
|
Customers : |
Wholesalers, Retailers And End Users |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
No. of Employees : |
150 (Approximately) |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Bankers : |
· Corporation Bank Industrial Finance Branch No.30, 1st Floor, 2nd Cr, Rallaram
Memorial Building, CSI Compound Mission Road, Bangalore - 560027, Karnataka,
India |
|||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
R. Natarajan Chartered Accountant |
|
Address : |
19/1, 2nd Floor, 6th Main, 9th Cross,
Malleswaram, Bangalore -560003, Karnataka, India |
|
Tel. No.: |
23348770 |
|
Mobile No.: |
91-9448067041 |
|
E-Mail : |
|
|
PAN No.: |
AANPR6508D |
CAPITAL STRUCTURE
As on: 30.09.2013
Authorized Capital: Rs. 100.000 Millions
Issued, Subscribed & Paid-up Capital: Rs. 59.351 Millions
As on: 31.03.2013
Authorized Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
500000 |
Equity Shares |
Rs.100/- each |
Rs. 50.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
334001 |
Equity Shares |
Rs.100/- each |
Rs. 33.400
Millions |
|
|
|
|
|
FINANCIAL DATA
[All figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
33.400 |
33.400 |
23.400 |
|
(b) Reserves & Surplus |
115.272 |
334.643 |
248.385 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
148.672 |
368.043 |
271.785 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
194.570 |
219.060 |
386.325 |
|
(b) Deferred tax liabilities (Net) |
8.907 |
10.652 |
1.596 |
|
(c) Other long term liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
31.033 |
31.033 |
31.033 |
|
Total Non-current Liabilities (3) |
234.510 |
260.745 |
418.954 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term
borrowings |
593.250 |
48.027 |
20.530 |
|
(b) Trade payables |
411.070 |
265.211 |
58.790 |
|
(c) Other current
liabilities |
3.184 |
0.810 |
3.851 |
|
(d) Short-term provisions |
16.006 |
13.030 |
7.545 |
|
Total Current Liabilities (4) |
1023.510 |
327.078 |
90.716 |
|
|
|
|
|
|
TOTAL |
1406.692 |
955.866 |
781.455 |
|
|
|
|
|
|
II. ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
687.351 |
492.054 |
64.043 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital
work-in-progress |
31.991 |
53.267 |
347.801 |
|
(iv) Intangible
assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.014 |
0.014 |
0.014 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
157.408 |
146.254 |
135.171 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current Assets |
876.764 |
691.589 |
547.029 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
296.161 |
146.155 |
96.544 |
|
(c) Trade receivables |
119.882 |
36.148 |
83.244 |
|
(d) Cash and cash
equivalents |
0.766 |
0.176 |
0.136 |
|
(e) Short-term loans
and advances |
113.119 |
81.798 |
54.502 |
|
(f) Other current
assets |
0.000 |
0.000 |
0.000 |
|
Total Current Assets |
529.928 |
264.277 |
234.426 |
|
|
|
|
|
|
TOTAL |
1406.692 |
955.866 |
781.455 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
598.437 |
451.606 |
411.952 |
|
|
|
Other Income |
0.761 |
0.553 |
44.429 |
|
|
|
TOTAL |
599.198 |
452.159 |
456.381 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
TOTAL |
661.802 |
408.821 |
429.092 |
|
|
|
|
|
|
|
|
Less |
PROFIT/
[LOSS] BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
(62.604) |
43.338 |
27.289 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
72.169 |
38.633 |
4.808 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
[LOSS] BEFORE TAX, DEPRECIATION AND AMORTISATION |
(134.773) |
4.705 |
22.481 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
86.211 |
38.465 |
5.552 |
|
|
|
|
|
|
|
|
|
Less |
PRIOR PERIOD
EXPENSES |
0.132 |
0.000 |
1.697 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ [LOSS]
BEFORE TAX |
(221.116) |
(33.760) |
15.232 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
(1.744) |
(9.056) |
5.293 |
|
|
|
|
|
|
|
|
|
|
PROFIT/ [LOSS]
AFTER TAX |
(219.372) |
(42.816) |
9.939 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’
BALANCE BROUGHT FORWARD |
33.219 |
76.035 |
66.096 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
(186.153) |
33.219 |
76.035 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
353.552 |
57.991 |
66.797 |
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
461.259 |
239.051 |
290.681 |
|
|
|
|
|
|
|
|
|
Earnings/ [Loss]
Per Share (Rs.) |
(656.80) |
(128.19) |
42.47 |
|
|
Particulars |
|
|
31.03.2014 |
|
Sales Turnover (Approximately) |
|
|
1200.000 |
The above information has been parted by Mr. Ganesh.
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
(36.61) |
(9.47) |
2.18 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
(36.95) |
(7.48) |
3.70 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(16.08) |
(3.74) |
3.51 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(1.49) |
(0.09) |
0.06 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
5.30 |
0.73 |
1.50 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
0.52 |
0.81 |
2.58 |
FINANCIAL ANALYSIS
[All figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Share Capital |
23.400 |
33.400 |
33.400 |
|
Reserves & Surplus |
248.385 |
334.643 |
115.272 |
|
Net worth |
271.785 |
368.043 |
148.672 |
|
|
|
|
|
|
long-term borrowings |
386.325 |
219.060 |
194.570 |
|
Short term borrowings |
20.530 |
48.027 |
593.250 |
|
Total borrowings |
406.855 |
267.087 |
787.820 |
|
Debt/Equity ratio |
1.497 |
0.726 |
5.299 |
%20PHARMA%20PRIVATE%20LIMITED%20-%20285543%2012-Sep-2014_files/image012.gif)
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Sales |
411.952 |
451.606 |
598.437 |
|
|
|
9.626 |
32.513 |
%20PHARMA%20PRIVATE%20LIMITED%20-%20285543%2012-Sep-2014_files/image013.gif)
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs. In Millions) |
(Rs. In Millions) |
(Rs. In Millions) |
|
Sales |
411.952 |
451.606 |
598.437 |
|
Profit |
9.939 |
(42.816) |
(219.372) |
|
|
2.41% |
(9.48%) |
(36.66%) |
%20PHARMA%20PRIVATE%20LIMITED%20-%20285543%2012-Sep-2014_files/image014.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report
(Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Mo |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact person |
Yes |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
-- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details (if applicable) |
Yes |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm / promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
Yes |
PERFORMANCE
The Company’s total turnover for the year was Rs. 598.437 Millions
(Previous year Rs. 451.606 Millions) comprising of Rs. 353.552 Millions from
Export Sales, Rs. 244.885 Millions from Domestic Sales.
UNSECURED LOANS
|
Particulars |
31.03.2013 (Rs.
In Millions) |
31.03.2012 (Rs.
In Millions) |
|
LONG-TERM
BORROWINGS |
|
|
|
From Corporate Bodies Couplet Limited |
105.513 |
94.366 |
|
Interest on Loan [Couplet Limited] |
1.267 |
1.463 |
|
|
|
|
|
Total |
106.780 |
95.829 |
INDEX OF CHARGES:
|
S.No. |
Charge ID |
Date of Charge Creation/Modification |
Charge amount secured |
Charge Holder |
Address |
Service Request Number (SRN) |
|
1 |
90199431 |
09/05/2001 |
36,000,000.00 |
CORPORATION BANK |
INDUSTRIAL FINANCE
BRANCH, BHARAT HOUSE; BOMBAY S |
- |
|
2 |
80010584 |
06/09/2006 * |
23,738,000.00 |
CORPORATION BANK |
INDUSTRIAL FINANCE BRANCH,
NO.1,, QUEENS ROAD,, B |
- |
|
3 |
80010585 |
29/06/2009 * |
380,000,000.00 |
CORPORATION BANK |
INDUSTRIAL FINANCE
BRANCH,NO.30, 1ST FLOOR, 2ND CR |
A66882986 |
FIXED ASSETS:
·
Land
·
Building Elevator
·
Electrical Installation
·
Furniture and Fixture
·
Lab Equipment
·
Office Equipment
·
Plant and Machinery
·
Fire Hydrant System
·
Pollution Control
·
Safety
·
Computers
·
Vehicle
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgment or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration:
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration:
No exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime:
Charges or conviction
registered against subject: None
5] on Violation of
Anti-Corruption Laws:
Charges or
investigation registered against subject: None
6] on Int’l Anti-Money
Laundering Laws/Standards:
Charges or
investigation registered against subject: None
7] Criminal
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government:
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package:
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report:
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.91 |
|
|
1 |
Rs.98.66 |
|
Euro |
1 |
Rs.78.63 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Analysis Done by
: |
SUM |
|
|
|
|
Report Prepared
by : |
JAY |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
29 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely
sound financial base with the strongest capability for timely payment of
interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working
capital. No caution needed for credit transaction. It has above average
(strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial &
operational base are regarded healthy. General unfavourable factors will not cause
fatal effect. Satisfactory capability for payment of interest and principal
sums |
Fairly
Large |
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial
difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are
apparent. Repayment of interest and principal sums in default or expected to
be in default upon maturity |
Limited
with full security |
|
<10 |
C |
Absolute credit risk
exists. Caution needed to be exercised |
Credit
not recommended |
|
-- |
NB |
New
Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.